Application of Artificial Intelligence in Schizophrenia Rehabilitation Management: A Systematic Scoping Review

• URL: http://arxiv.org/abs/2405.10883v2
• Date: Sat, 25 Jan 2025 05:18:29 GMT
• Title: Application of Artificial Intelligence in Schizophrenia Rehabilitation Management: A Systematic Scoping Review
• Authors: Hongyi Yang, Fangyuan Chang, Dian Zhu, Muroi Fumie, Zhao Liu,
• Abstract summary: This systematic review assessed the current state and future prospects of artificial intelligence (AI) in schizophrenia rehabilitation management.<n>We reviewed 61 studies on AI-related data types, feature engineering methods, algorithmic models, and evaluation metrics published from 2012-2024.
• Score: 4.619934969700147
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: This systematic review assessed the current state and future prospects of artificial intelligence (AI) in schizophrenia rehabilitation management. We reviewed 61 studies on AI-related data types, feature engineering methods, algorithmic models, and evaluation metrics published from 2012-2024. The review categorizes AI applications into the following key application areas: symptom monitoring, medication management, risk management, functional training, and psychosocial support. Findings indicate that supervised machine learning techniques, particularly for symptom monitoring and relapse risk management, remain the predominant approaches, effectively leveraging structured data while incorporating interpretable algorithms. This study underscores the potential of AI in transforming long-term management strategies for schizophrenia, offering valuable insights into improving the quality of life of patients. Future research should focus on expanding data sources through multimodal data integration, exploring deep learning models, and integrating AI-driven interventions into training tasks to fully capitalize on AI's potential in schizophrenia rehabilitation.

Related papers

• Artificial Intelligence for Personalized Prediction of Alzheimer's Disease Progression: A Survey of Methods, Data Challenges, and Future Directions [0.8249694498830561]
  Alzheimer's Disease (AD) is marked by significant inter-individual variability in its progression. This review aims to consolidate current knowledge and guide future efforts in developing clinically relevant AI tools for personalized AD prognostication.
  arXiv  Detail & Related papers  (2025-04-29T21:45:28Z)
• Analyzing the Impact of AI Tools on Student Study Habits and Academic Performance [0.0]
  The research focuses on how AI tools can support personalized learning, adaptive test adjustments, and provide real-time classroom analysis. Student feedback revealed strong support for these features, and the study found a significant reduction in study hours alongside an increase in GPA. Despite these benefits, challenges such as over-reliance on AI and difficulties in integrating AI with traditional teaching methods were also identified.
  arXiv  Detail & Related papers  (2024-12-03T04:51:57Z)
• Artificial intelligence techniques in inherited retinal diseases: A review [19.107474958408847]
  Inherited retinal diseases (IRDs) are a diverse group of genetic disorders that lead to progressive vision loss and are a major cause of blindness in working-age adults. Recent advancements in artificial intelligence (AI) offer promising solutions to these challenges. This review consolidates existing studies, identifies gaps, and provides an overview of AI's potential in diagnosing and managing IRDs.
  arXiv  Detail & Related papers  (2024-10-10T03:14:51Z)
• A Survey of Models for Cognitive Diagnosis: New Developments and Future Directions [66.40362209055023]
  This paper aims to provide a survey of current models for cognitive diagnosis, with more attention on new developments using machine learning-based methods. By comparing the model structures, parameter estimation algorithms, model evaluation methods and applications, we provide a relatively comprehensive review of the recent trends in cognitive diagnosis models.
  arXiv  Detail & Related papers  (2024-07-07T18:02:00Z)
• Reporting Risks in AI-based Assistive Technology Research: A Systematic Review [2.928964540437144]
  We conducted a systematic literature review of research into AI-based assistive technology for persons with visual impairments. Our study shows that most proposed technologies with a testable prototype have not been evaluated in a human study with members of the sight-loss community.
  arXiv  Detail & Related papers  (2024-07-01T05:22:44Z)
• AI for the prediction of early stages of Alzheimer's disease from neuroimaging biomarkers -- A narrative review of a growing field [0.0]
  Single-modality studies using structural MRI and PET imaging have demonstrated high accuracy in classifying AD. Multi-modality studies, integrating multiple neuroimaging techniques and biomarkers, have shown improved performance and robustness. challenges remain in data standardization, model interpretability, generalizability, clinical integration, and ethical considerations.
  arXiv  Detail & Related papers  (2024-06-25T09:22:53Z)
• A Survey of Artificial Intelligence in Gait-Based Neurodegenerative Disease Diagnosis [51.07114445705692]
  neurodegenerative diseases (NDs) traditionally require extensive healthcare resources and human effort for medical diagnosis and monitoring. As a crucial disease-related motor symptom, human gait can be exploited to characterize different NDs. The current advances in artificial intelligence (AI) models enable automatic gait analysis for NDs identification and classification.
  arXiv  Detail & Related papers  (2024-05-21T06:44:40Z)
• Emotional Intelligence Through Artificial Intelligence : NLP and Deep Learning in the Analysis of Healthcare Texts [1.9374282535132377]
  This manuscript presents a methodical examination of the utilization of Artificial Intelligence in the assessment of emotions in texts related to healthcare. We scrutinize numerous research studies that employ AI to augment sentiment analysis, categorize emotions, and forecast patient outcomes. There persist challenges, which encompass ensuring the ethical application of AI, safeguarding patient confidentiality, and addressing potential biases in algorithmic procedures.
  arXiv  Detail & Related papers  (2024-03-14T15:58:13Z)
• Unmasking Biases and Navigating Pitfalls in the Ophthalmic Artificial Intelligence Lifecycle: A Review [3.1929071422400446]
  This review article breaks down the AI lifecycle into seven steps. Data collection; defining the model task; data pre-processing and labeling; model development; model evaluation and validation; deployment. Finally, post-deployment evaluation, monitoring, and system recalibration and delves into the risks for harm at each step and strategies for mitigating them.
  arXiv  Detail & Related papers  (2023-10-08T03:49:42Z)
• Incomplete Multimodal Learning for Complex Brain Disorders Prediction [65.95783479249745]
  We propose a new incomplete multimodal data integration approach that employs transformers and generative adversarial networks. We apply our new method to predict cognitive degeneration and disease outcomes using the multimodal imaging genetic data from Alzheimer's Disease Neuroimaging Initiative cohort.
  arXiv  Detail & Related papers  (2023-05-25T16:29:16Z)
• Safe AI for health and beyond -- Monitoring to transform a health service [51.8524501805308]
  We will assess the infrastructure required to monitor the outputs of a machine learning algorithm. We will present two scenarios with examples of monitoring and updates of models.
  arXiv  Detail & Related papers  (2023-03-02T17:27:45Z)
• The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies [97.5153823429076]
  The benefits, challenges and drawbacks of AI in this field are reviewed. The use of data augmentation, explainable AI, and the integration of AI with traditional experimental methods are also discussed.
  arXiv  Detail & Related papers  (2022-12-08T23:23:39Z)
• ImDrug: A Benchmark for Deep Imbalanced Learning in AI-aided Drug Discovery [79.08833067391093]
  Real-world pharmaceutical datasets often exhibit highly imbalanced distribution. We introduce ImDrug, a benchmark with an open-source Python library which consists of 4 imbalance settings, 11 AI-ready datasets, 54 learning tasks and 16 baseline algorithms tailored for imbalanced learning. It provides an accessible and customizable testbed for problems and solutions spanning a broad spectrum of the drug discovery pipeline.
  arXiv  Detail & Related papers  (2022-09-16T13:35:57Z)
• Automated Fidelity Assessment for Strategy Training in Inpatient Rehabilitation using Natural Language Processing [53.096237570992294]
  Strategy training is a rehabilitation approach that teaches skills to reduce disability among those with cognitive impairments following a stroke. Standardized fidelity assessment is used to measure adherence to treatment principles. We developed a rule-based NLP algorithm, a long-short term memory (LSTM) model, and a bidirectional encoder representation from transformers (BERT) model for this task.
  arXiv  Detail & Related papers  (2022-09-14T15:33:30Z)
• Enabling AI and Robotic Coaches for Physical Rehabilitation Therapy: Iterative Design and Evaluation with Therapists and Post-Stroke Survivors [66.07833535962762]
  Artificial intelligence (AI) and robotic coaches promise the improved engagement of patients on rehabilitation exercises through social interaction. Previous work explored the potential of automatically monitoring exercises for AI and robotic coaches, but deployment remains a challenge. We present our efforts on eliciting the detailed design specifications on how AI and robotic coaches could interact with and guide patient's exercises.
  arXiv  Detail & Related papers  (2021-06-15T22:06:39Z)
• AI-Augmented Behavior Analysis for Children with Developmental Disabilities: Building Towards Precision Treatment [2.0324247356209835]
  We present an AI-Augmented Learning and Applied Behavior Analytics (AI-ABA) platform to provide personalized treatment and learning plans. By defining systematic experiments along with automated data collection and analysis, AI-ABA can promote self-regulative behavior.
  arXiv  Detail & Related papers  (2021-02-21T16:15:40Z)
• Achievements and Challenges in Explaining Deep Learning based Computer-Aided Diagnosis Systems [4.9449660544238085]
  We discuss early achievements in development of explainable AI for validation of known disease criteria. We highlight some of the remaining challenges that stand in the way of practical applications of AI as a clinical decision support tool.
  arXiv  Detail & Related papers  (2020-11-26T08:08:19Z)
• Review of Machine Learning Algorithms for Brain Stroke Diagnosis and Prognosis by EEG Analysis [50.591267188664666]
  Strokes are the leading cause of adult disability in the United States. Brain-Computer Interfaces (BCIs) help the patient either restore neurologic pathways or effectively communicate with an electronic prosthetic. The various machine learning techniques and algorithms that are addressed and combined with BCIs technology show that the use of BCIs for stroke treatment is a promising and rapidly expanding field.
  arXiv  Detail & Related papers  (2020-08-06T19:50:29Z)
• Hierarchical Reinforcement Learning for Automatic Disease Diagnosis [52.111516253474285]
  We propose to integrate a hierarchical policy structure of two levels into the dialogue systemfor policy learning. The proposed policy structure is capable to deal with diagnosis problem including large number of diseases and symptoms.
  arXiv  Detail & Related papers  (2020-04-29T15:02:41Z)
• A Review of Computational Approaches for Evaluation of Rehabilitation Exercises [58.720142291102135]
  This paper reviews computational approaches for evaluating patient performance in rehabilitation programs using motion capture systems. The reviewed computational methods for exercise evaluation are grouped into three main categories: discrete movement score, rule-based, and template-based approaches.
  arXiv  Detail & Related papers  (2020-02-29T22:18:56Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.